Paul Mango serves as Executive at Pear Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Paul Mango has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 15, 2023 involved receiving (via award) 52,380 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Feb 15, 2023 | PEAR | $0 | Award | 52,380 | $N/A | Discretionary |
Paul Mango currently holds 52,380 shares of Pear Therapeutics, Inc. (PEAR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Paul Mango has been a net neutral trader of PEAR stock. They have purchased $0 and sold $0 worth of shares.
Paul Mango's most recent insider trade was on Feb 15, 2023, when they sold 52,380 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted